IGC Pharma Inc (IGC)

IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	33	25	18	48	81	19
Market Cap Growth	41.48%	41.48%	-62.80%	-40.34%	321.48%	-76.60%
Enterprise Value	31	24	15	37	64	6
PE Ratio	-	-1.96	-1.57	-3.23	-9.22	-2.63
PS Ratio	24.19	18.95	19.78	122.03	90.43	4.73
PB Ratio	4.44	3.48	1.21	2.03	2.48	0.73
P/FCF Ratio	-4.82	-4.82	-2.64	-6.32	-6.62	-1.47
P/OCF Ratio	-4.90	-4.90	-2.56	-6.49	-7.52	-2.22
EV/Sales Ratio	23.31	18.07	16.09	94.44	71.63	1.58
EV/EBITDA Ratio	-1.97	-1.97	-1.35	-2.61	-7.72	-0.90
EV/EBIT Ratio	-1.87	-1.87	-1.27	-2.50	-7.30	-0.88
EV/FCF Ratio	-4.59	-4.59	-2.15	-4.89	-5.24	-0.49
Debt / Equity Ratio	0.03	0.03	0.02	0.02	0.03	0.02
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	-0.03	-0.12	-0.07
Debt / FCF Ratio	-0.04	-0.04	-0.05	-0.06	-0.08	-0.04
Quick Ratio	0.62	0.62	2.01	4.74	7.62	6.94
Current Ratio	1.58	1.58	3.41	6.19	9.93	9.13
Asset Turnover	0.10	0.10	0.04	0.01	0.03	0.13
Return on Equity (ROE)	-119.10%	-119.10%	-61.00%	-51.60%	-34.30%	-24.40%
Return on Assets (ROA)	-97.50%	-97.50%	-55.20%	-47.50%	-30.70%	-23.10%
Return on Capital (ROIC)	-129.91%	-129.91%	-75.83%	-63.29%	-25.82%	-25.35%
Earnings Yield	-39.96%	-50.99%	-63.85%	-31.00%	-10.85%	-37.97%
FCF Yield	-16.27%	-20.76%	-37.84%	-15.83%	-15.11%	-67.82%
Buyback Yield / Dilution	-11.91%	-11.91%	-5.17%	-19.13%	-6.26%	-11.58%
Total Shareholder Return	-11.91%	-11.91%	-5.17%	-19.13%	-6.26%	-11.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).